Atlas Trials

Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis

Clinical trial NCT02243787 · TERMINATED

Trial details

NCT number
NCT02243787
Sponsor
Covagen
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Plaque Psoriasis
Start date
2014-04-01
Primary completion
2015-09-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.